Literature DB >> 35648301

Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma.

Liqiong Yang1,2,3, Tao Zou1,2,3, Yao Chen1,2,3, Yueshui Zhao1,2,3, Xu Wu1,2,3, Mingxing Li1,2,3, Fukuan Du1,2,3, Yu Chen1,2,3, Zhangang Xiao4,5,6, Jing Shen7,8,9.   

Abstract

Chronic hepatitis B virus (HBV) infection is a worldwide health problem. Hepatitis B virus X protein (HBx), a pleiotropic regulatory protein encoded by HBV, is necessary for the transcription of HBV covalently closed circular DNA (cccDNA) minichromosomes, and affects the epigenetic regulation of host cells. The epigenetic reprogramming of HBx on host cell genome is strongly involved in HBV-related HCC carcinogenesis. Here, we review the latest findings of the epigenetic regulation induced by HBx protein in hepatocellular carcinoma (HCC), including DNA methylation, histone modification and non-coding RNA expression. The influence of HBx on the epigenetic regulation of cccDNA is also summarized. In addition, preliminary studies of targeted drugs for epigenetic changes induced by HBx are also discussed. The exploration of epigenetic markers as potential targets will help to develop new prevention and/or treatment methods for HBx-related HCC.
© 2022. Asian Pacific Association for the Study of the Liver.

Entities:  

Keywords:  Epigenetic regulation; HBx; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2022        PMID: 35648301     DOI: 10.1007/s12072-022-10351-6

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   9.029


  119 in total

Review 1.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  C-terminal truncated HBx protein activates caveolin-1/LRP6/β-catenin/FRMD5 axis in promoting hepatocarcinogenesis.

Authors:  Xiaowen Mao; Sze Keong Tey; Frankie Chi Fat Ko; Ernest Man Lok Kwong; Yi Gao; Irene Oi-Lin Ng; Siu Tim Cheung; Xin-Yuan Guan; Judy Wai Ping Yam
Journal:  Cancer Lett       Date:  2018-12-21       Impact factor: 8.679

3.  Recent Trends in the Global Burden of Hepatitis B Virus: 2007-2017.

Authors:  James M Paik; Youssef Younossi; Linda Henry; Alita Mishra; Zobair M Younossi
Journal:  Gastroenterology       Date:  2021-01-06       Impact factor: 22.682

4.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

5.  A global scientific strategy to cure hepatitis B.

Authors:  Peter A Revill; Francis V Chisari; Joan M Block; Maura Dandri; Adam J Gehring; Haitao Guo; Jianming Hu; Anna Kramvis; Pietro Lampertico; Harry L A Janssen; Massimo Levrero; Wenhui Li; T Jake Liang; Seng-Gee Lim; Fengmin Lu; M Capucine Penicaud; John E Tavis; Robert Thimme; Fabien Zoulim
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

6.  Analysis of the X gene promoter of woodchuck hepatitis virus.

Authors:  F Sugata; H S Chen; S Kaneko; R H Purcell; R H Miller
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

7.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.

Authors:  Jeffrey D Stanaway; Abraham D Flaxman; Mohsen Naghavi; Christina Fitzmaurice; Theo Vos; Ibrahim Abubakar; Laith J Abu-Raddad; Reza Assadi; Neeraj Bhala; Benjamin Cowie; Mohammad H Forouzanfour; Justina Groeger; Khayriyyah Mohd Hanafiah; Kathryn H Jacobsen; Spencer L James; Jennifer MacLachlan; Reza Malekzadeh; Natasha K Martin; Ali A Mokdad; Ali H Mokdad; Christopher J L Murray; Dietrich Plass; Saleem Rana; David B Rein; Jan Hendrik Richardus; Juan Sanabria; Mete Saylan; Saeid Shahraz; Samuel So; Vasiliy V Vlassov; Elisabete Weiderpass; Steven T Wiersma; Mustafa Younis; Chuanhua Yu; Maysaa El Sayed Zaki; Graham S Cooke
Journal:  Lancet       Date:  2016-07-07       Impact factor: 79.321

Review 8.  Epidemiology of Hepatocellular Carcinoma.

Authors:  Katherine A McGlynn; Jessica L Petrick; Hashem B El-Serag
Journal:  Hepatology       Date:  2020-11-24       Impact factor: 17.298

9.  USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.

Authors:  Yu Qian; Boshi Wang; Aihui Ma; Li Zhang; Guiqin Xu; Qi Ding; Tiantian Jing; Lin Wu; Yun Liu; Zhaojuan Yang; Yongzhong Liu
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

10.  Preclinical Evaluation of In Vitro and In Vivo Antiviral Activities of KCT-01, a New Herbal Formula against Hepatitis B Virus.

Authors:  Hong Kim; Eungyeong Jang; So-Young Kim; Ji-Yoon Choi; Na-Rae Lee; Dae-Sung Kim; Kyung-Tae Lee; Kyung-Soo Inn; Bum-Joon Kim; Jang-Hoon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.